SynthesisPharmacoEconomics2018
Disease-Modifying Therapies for Multiple Sclerosis: A Systematic Literature Review of Cost-Effectiveness Studies.
Sergio Iannazzo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it